National Institutes of Health Consensus Development Conference. Adjuvant therapy for patients with colon and rectum cancer. Consens Statement. 1990;8(4):1–25.

Google Scholar 

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–40.

Article  CAS  PubMed  Google Scholar 

Breugom AJ, Swets M, Bosset JF, Collette L, Sainato A, Cionini L, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data. Lancet Oncol. 2015;16(2):200–7.

Article  CAS  PubMed  Google Scholar 

Petersen SH, Harling H, Kirkeby LT, Wille-Jorgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;3:CD004078.

Google Scholar 

Hajibandeh S, Hajibandeh S. Systematic review: adjuvant chemotherapy for locally advanced rectal cancer with respect to stage of disease. Int Sch Res Notices. 2015;2015: 710569.

PubMed  PubMed Central  Google Scholar 

Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988;80(1):21–9.

Article  CAS  PubMed  Google Scholar 

The Colorectal Cancer Chemotherapy Study Group of Japan. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan. Jpn J Clin Oncol. 1995;25(3):91-103.

Kodaira S. Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer. Oncology (Williston Park). 1997;11(9 Suppl 10):40–3.

CAS  PubMed  Google Scholar 

Kato T, Ohashi Y, Nakazato H, Koike A, Saji S, Suzuki H, et al. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbecks Arch Surg. 2002;386(8):575–81.

Article  CAS  PubMed  Google Scholar 

Glimelius B, Dahl O, Cedermark B, Jakobsen A, Bentzen SM, Starkhammar H, et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the nordic gastrointestinal tumour adjuvant therapy group. Acta Oncol. 2005;44(8):904–12.

Article  CAS  PubMed  Google Scholar 

Sakamoto J, Hamada C, Yoshida S, Kodaira S, Yasutomi M, Kato T, et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer. 2007;96(8):1170–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamaguchi T, Shirao K, Moriya Y, Yoshida S, Kodaira S, Ohashi Y, et al. Final results of randomized trials by the National Surgical Adjuvant Study of Colorectal Cancer (NSAS-CC). Cancer Chemother Pharmacol. 2011;67(3):587–96.

Article  CAS  PubMed  Google Scholar 

Petrelli F, Coinu A, Lonati V, Barni S. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer. Int J Colorectal Dis. 2015;30(4):447–57.

Article  PubMed  Google Scholar 

Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali AM, et al. Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev. 2020;83: 101948.

Article  CAS  PubMed  Google Scholar 

Pahlman LA, Hohenberger WM, Matzel K, Sugihara K, Quirke P, Glimelius B. Should the benefit of adjuvant chemotherapy in colon cancer be re-evaluated? J Clin Oncol. 2016;34(12):1297–9.

Article  PubMed  Google Scholar 

Chapuis PH, Bokey E, Chan C, Keshava A, Rickard M, Stewart P, et al. Recurrence and cancer-specific death after adjuvant chemotherapy for stage III colon cancer. Colorectal Dis. 2019;21(2):164–73.

Article  CAS  PubMed  Google Scholar 

Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–9.

Article  CAS  PubMed  Google Scholar 

Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389–430.

Article  CAS  PubMed  Google Scholar 

Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695–706.

Article  CAS  PubMed  Google Scholar 

Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newland RC, Chapuis PH, Pheils MT, MacPherson JG. The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer. 1981;47(6):1424–9.

Article  CAS  PubMed  Google Scholar 

Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging colorectal carcinoma. a prospective study of 1117 cases with standardized pathology. Cancer. 1987;60(4):852–7.

Article  CAS  PubMed  Google Scholar 

Bokey EL, Ojerskog B, Chapuis PH, Dent OF, Newland RC, Sinclair G. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg. 1999;86(9):1164–70.

Article  CAS  PubMed  Google Scholar 

Bokey L, Chapuis PH, Keshava A, Rickard MJ, Stewart P, Dent OF. Complications after resection of colorectal cancer in a public hospital and a private hospital. ANZ J Surg. 2015;85(3):128–34.

Article  PubMed  Google Scholar 

Davis NC, Newland RC. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. Aust N Z J Surg. 1983;53(3):211–21.

Article  CAS  PubMed  Google Scholar 

Chapuis PH, Dent OF, Bokey EL, Newland RC, Sinclair G. Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg. 2004;91(3):349–54.

Article  CAS  PubMed  Google Scholar 

Poon MA, O’Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7(10):1407–18.

Article  CAS  PubMed  Google Scholar 

Petrelli N, Douglass Jr HO, Herrera L, Russell D, Stablein DM, Bruckner HW, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol. 1989;7(10):1419–26.

Article  CAS  PubMed  Google Scholar 

Andre T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol. 2003;21(15):2896–903.

Article  CAS  PubMed  Google Scholar 

de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18(16):2938–47.

Article  PubMed  Google Scholar 

Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.

Article  Google Scholar 

Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322(6):352–8.

Article  CAS  PubMed  Google Scholar 

Tiselius C, Gunnarsson U, Smedh K, Glimelius B, Pahlman L. Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study. Ann Oncol. 2013;24(1):160–5.

Article  CAS  PubMed  Google Scholar 

Punt CJ, Buyse M, Kohne CH, Hohenberger P, Labianca R, Schmoll HJ, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007;99(13):998–1003.

Article  PubMed  Google Scholar 

You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, et al. The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer. Dis Colon Rectum. 2020;63(9):1191–222.

Article  PubMed  Google Scholar 

Gollins S, Moran B, Adams R, Cunningham C, Bach S, Myint AS, et al. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Multidisciplinary Management. Colorectal Dis. 2017;19(Suppl 1):37–66.

Article  PubMed  Google Scholar 

Cancer Council Australia Colorectal Cancer Guidelines Working Party. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney: Cancer Council Australia; 2022. Available from: https://wiki.cancer.org.au/australia/Guidelines:Colorectal_cancer.